Use of Moxifloxacin Injection for Inpatients in Peking Union Medical College Hospital
-
摘要:
目的 调查2010年全年和2011年第1季度莫西沙星注射液在本院的使用情况, 并对其中53例患者的应用进行回顾性分析。 方法 通过北京协和医院信息系统获取2010年全年和2011年第1季度莫西沙星注射液使用数据, 查阅其中53例患者的病历, 记录用药目的、用药量、手术类型等相关数据并进行分析评价。 结果 与2010年第1季度相比, 2011年第1季度莫西沙星注射液使用量同比增幅5.15%, 手术预防用药使用量同比增幅20.51%;患者个人用药总量逐渐增多(P=0.003), 18岁以下患者人数从2010年第1季度的2例增长至2011年第1季度的6例。53例患者中45例为手术患者, 其中39例(86.7%)将莫西沙星作为手术预防用药。21例具有感染病症患者的病原学送检率为52.38%(11例)。 结论 莫西沙星注射液的应用较为广泛, 但部分应用存在不合理性, 尤其是手术预防用药, 应加强抗生素用药管理并对不合理用药进行干预。 Abstract:Objective To analyze the recent use of moxifloxacin injection in a tertiary hospital in Beijing. Methods The use of moxifloxacin injection among inpatients in Peking Union Medical College Hospital in 2010 and the first quarter of 2011 was analyzed based on the hospital information system database. Meanwhile, the clinical records of 53 patients were reviewed for relevant data including medication purpose, dosage, and surgical procedures. Results Compared to the first quarter of 2010, the total usage of moxifloxacin injection increased by 5.15% and the preoperative prophylaxis usage by 20.51% in the first quarter of 2011. The individual consumption also showed a growing tendency(P=0.003). With the number of patients younger than 18 years increased from 2 in the first quarter of 2010 to 6 in the first quarter of 2011. Of 45 patients who had preoperatively received moxifloxacin, 39 (86.7%) were for prophylaxis purpose. Of 21 patients with infectious diseases, etiological inspection was performed in 11 patients (52.38%). Conclusion Moxifloxacin injection has been widely used in our hospital. However, its administration is not always rational, especially when applied for preoperative prophylaxis. -
Key words:
- moxifloxacin /
- medication use evaluation /
- preoperative prophylaxis
-
表 1 2010年全年与2011年第1季度各科室莫西沙星用量
表 2 2010年全年和2011年第1季度各科室手术预防莫西沙星用量
表 3 莫西沙星个人用药总量患者人数
表 4 应用莫西沙星各年龄段患者人数
表 5 2010年第1季度与2011年第1季度53例莫西沙星用药病历分析
-
[1] Mean M, Pavese P, Vittoz JP, et al.Prospective assessment of fluoroquinolone use in a teaching hospital[J]. Eur J Clin Microbiol Infect Dis, 2006, 25:757-763. doi: 10.1007/s10096-006-0221-0 [2] Pulcini C, Mondain V, Lieutier F, et al.Fluoroquinolone prescriptions in a teaching hospital:a prospective audit[J]. Scand J Infect Dis, 2007, 39(11-12):1013-1017. doi: 10.1080/00365540701466223 [3] Micromedex (147)[DB/OL]. Thomson Reuters (Healthcare) Inc. company, 2011[2011-06-20]. http://www.thomsonhc.com/home/dispatch. [4] 中华外科杂志编辑委员会, 中华医学会外科学分会.围手术期预防应用抗菌药物指南[J].中华外科杂志, 2006, 44:1594-1596. http://www.cnki.com.cn/Article/CJFDTotal-ZHWK200623003.htm [5] 中华人民共和国卫生部.关于抗菌药物临床应用管理有关问题的通知[Z]. 2009. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s9508/200903/39723.htm. [6] Alfandari S, Levent T, Descamps D, et al.Evaluation of glycopeptide use in nine French hospitals[J].Med Mal Infect, 2010, 40:232-237. doi: 10.1016/j.medmal.2009.10.019 [7] Pawar PK, Katara R, Majumdar DK. Design and evaluation of moxifloxacin hydrochloride ocular inserts[J].Acta Pharm, 2012, 62:93-104. doi: 10.2478/v10007-012-0002-5 [8] Samilski JA, Lau TT, Elbe DH, et al.Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a Canadian teaching hospital[J]. PT, 2012, 37:291-299. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=95a5cd5eae137d564026490d37af7639
计量
- 文章访问数: 162
- HTML全文浏览量: 57
- PDF下载量: 4
- 被引次数: 0